20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11526 | DPP-IV-IN-2 | H-Lys(4-nitro-Z)-pyrrolidide | DPP-4 |
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM). | |||
T10082 | DPP-IV-IN-1 | Others | |
DPP-IV-IN-1 is an effective inhibitor of dipeptidyl peptidase IV (DPP-IV), a serine protease (IC50: 4.6 nM). | |||
T74978 | DPP IV/hCA II-IN-1 | ||
DPP IV/hCA II-IN-1 is a potent, selective inhibitor of dipeptidyl peptidase IV (DPP IV) and carbonic anhydrase (CA), exhibiting an IC50 of 0.049 μM for DPP IV and K_i values of 0.0361, 0.0428, 0.0941, 0.1328, 0.2615, and... | |||
T1502 | Vildagliptin | NVP-LAF 237,LAF237 | Apoptosis , Ferroptosis , Proteasome , DPP-4 |
Vildagliptin (LAF237) is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolit... | |||
TN1418 | Azaleatin | DPP-4 | |
Azaleatin is a natural product from Rhododendron simsii. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for type-2 diabetes and obesity studies. | |||
T25340 | Diprotin A | Ile-Pro-Ile | DPP-4 |
Diprotin A (Ile-Pro-Ile) (Ile-Pro-Ile) is a dipeptidyl peptidase IV (DPP-IV) inhibitor. | |||
T78410 | Gly-Pro-AMC hydrobromide | Gly-Pro-AMC HCl | |
Gly-Pro-AMC hydrobromide (Gly-Pro-AMC HCl) is a specific fluorescent dye used in cytofluorescence assays to detect Dipeptidyl peptidase IV (DPP-IV) activity. | |||
T78223 | γ-Glu-Tyr | gamma-Glutamyltyrosine,gamma-GLU-TYR | |
γ-Glu-Tyr (gamma-Glutamyltyrosine) is a kokumi peptide with competitive inhibition of dipeptidyl peptidase-IV (DPP-IV) and is used in the study of diabetes mellitus. | |||
T0242L | Sitagliptin phosphate monohydrate | MK-0431,MK-0431 phosphate monohydrate | Proteasome , DPP-4 , Autophagy |
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP-IV with IC50 of 19 nM in Caco-2 cell extracts. | |||
T68053 | Denagliptin | GW823093 | DPP-4 |
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of type 2 diabetes. | |||
T1674 | Nateglinide | A4166,Senaglinide | Potassium Channel , Proteasome , PPAR |
Nateglinide (Senaglinide) is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare ins... | |||
T11049 | Diprotin A TFA | Ile-Pro-Pro (TFA) | Others |
Diprotin A (TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV). | |||
T31378 | Denagliptin tosylate | GSK-823093,GSK 823093,GW-823093,GW 823093,GSK823093,GW823093 | |
Denagliptin (GW823093 or GSK-823093) is a dipeptidyl peptidase IV (DPP-IV) inhibitor. | |||
T63698 | PK44 phosphate | ||
PK44 phosphate is a potent inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50: 15.8 nM). | |||
T13826 | Prodipine hydrochloride | Others | |
Prodipine hydrochloride for purified and plasma Dipeptidyl peptidase IV (DPP IV) from the rabbit (IC50 of 4.5 μM and 30 μM, respectively). | |||
T61414 | DPP-4 inhibitor 3 | ||
Compound 5a, also known as DPP-4 inhibitor 3, is a powerful dipeptidyl peptidase IV (DPP-IV) inhibitor, demonstrating an IC50 value of 0.75 nM. It exhibits outstanding antioxidant and insulinotropic activity [1]. | |||
T26850 | BMS-538305 HCl | BMS-538305,BMS538305,BMS 538305,BMS-538305 hydrochloride | |
BMS-538305 is a potent, selective inhibitor of dipeptidyl peptidase IV (DPP-IV). | |||
T63964 | DPP-4/GPR119 modulator 2 | ||
DPP-4/GPR119 modulator 2 is an inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50: 0.22 μM) and an agonist of GPR119 (EC50: 0.95 μM). | |||
T79911 | O-Benzoylhydroxylamine | ||
O-Benzoyl hydroxylamine exhibits properties as a dipeptidyl peptidase-IV (DPP-IV) inhibitor and demonstrates antidiabetic effects[1]. | |||
T26941 | Camegliptin | RO-4876904-001,R1579,RG1579,RO-4876904,R-1579,RG-1579 | |
Cameglipti, a dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type 2 diabetes. |